• Markets
    • icon
  • Companies
GTG · ASX

Genetic Technologies Limited (ASX:GTG)

AU$0.039

 -0.003 (-7.143%)
ASX:Live
16/09/2024 02:32:20 PM
HALO Ords GROWTH AUS All-Consensus All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

GTG Overview

GTG Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Strong

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About GTG

Website

Genetic Technologies Limited

Telephone

61.3.8412.7000

Address

60-66 Hanover Street Fitzroy, Victoria (VIC) 3065

Description

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through ,the EasyDNA, AffinityDNA, and GeneType/Corporate segments. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

GTG Price Chart

Key Stats

Market Cap

AU$9.45M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.04 - 0.29

Trade Value (12mth)

AU$2,188.00

1 week

5%

1 month

0%

YTD

-66.19%

1 year

-82.42%

All time high

77.59

Key Fundamentals

EPS 3 yr Growth

25.50%

EBITDA Margin

-157.20%

Operating Cashflow

-$10m

Free Cash Flow Return

-144.00%

ROIC

-181.50%

Interest Coverage

-233.40

Quick Ratio

0.80

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Industrials

Next Company Report Date

28-Aug-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

GTG Announcements

Latest Announcements

Date Announcements

11 September 24

GTG invited to join prestigious CancerIQ platform

×

GTG invited to join prestigious CancerIQ platform

11 September 24

Entitlement Offer Results and Closing

×

Entitlement Offer Results and Closing

30 August 24

Preliminary Final Report

×

Preliminary Final Report

30 August 24

FY24 results announcement and operations update

×

FY24 results announcement and operations update

28 August 24

Non-Renounceable Issue extension of Closing Date

×

Non-Renounceable Issue extension of Closing Date

28 August 24

Update - Proposed issue of securities - GTG

×

Update - Proposed issue of securities - GTG

15 August 24

Global launch of geneType on EasyDNA platform

×

Global launch of geneType on EasyDNA platform

12 August 24

Eligible shareholders access letter

×

Eligible shareholders access letter

12 August 24

Ineligible shareholders letter

×

Ineligible shareholders letter

02 August 24

Lodgement of Prospectus - Non-renounceable Entitlement Offer

×

Lodgement of Prospectus - Non-renounceable Entitlement Offer

02 August 24

Entitlement Offer Prospectus

×

Entitlement Offer Prospectus

31 July 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

26 July 24

Strategic restructure to focus on USA sales growth

×

Strategic restructure to focus on USA sales growth

26 July 24

Proposed issue of securities - GTG

×

Proposed issue of securities - GTG

19 July 24

Change in substantial holding

×

Change in substantial holding

18 July 24

Change in substantial holding

×

Change in substantial holding

16 July 24

Appointment of CFO and Company Secretary

×

Appointment of CFO and Company Secretary

16 July 24

Application for quotation of securities - GTG

×

Application for quotation of securities - GTG

16 July 24

S708A Cleansing Notice

×

S708A Cleansing Notice

12 July 24

Change in substantial holding

×

Change in substantial holding

09 July 24

GeneType to Enter Canadian and New Zealand Markets

×

GeneType to Enter Canadian and New Zealand Markets

28 June 24

Business Update - June 2024

×

Business Update - June 2024

28 June 24

Resignation of CFO and Company Secretary

×

Resignation of CFO and Company Secretary

25 June 24

GeneType identifies 79.5% at risk of serious disease

×

GeneType identifies 79.5% at risk of serious disease

24 June 24

Change in substantial holding

×

Change in substantial holding

GTG Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.07 -0.11 -0.10 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.07 -0.11 -0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.2 -50.5 10.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.06 -0.09 -0.07 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.06 -0.09 -0.08 Lock Lock Lock
     Growth % Lock Lock Lock Lock 4.0 -58.0 27.1 Lock Lock Lock
     Yield % Lock Lock Lock Lock -20.6 -37.7 -110.5 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.17 0.12 0.01 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.12 0.08 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -48.8 -33.4 -102.9 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 96 106 121 Lock Lock Lock
Basic m Lock Lock Lock Lock 96 106 121 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 7 9 8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 5,536.3 27.8 -11.8 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 7 9 8 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -2 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -272.1 -4.4 -73.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -35.0 -28.6 -56.2 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 135 129 156 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -9 -11 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -6.8 -27.3 -8.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -128.2 -127.7 -157.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -9 -12 -13 Lock Lock Lock
     Growth % Lock Lock Lock Lock -7.6 -26.7 -6.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -136.7 -135.4 -164.1 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -10 -14 -14 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -2 -2 -2 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -7 -12 -12 Lock Lock Lock
     Growth % Lock Lock Lock Lock -0.8 -64.8 -2.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock -104.9 -135.3 -156.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -6 -10 -10 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -3 -1 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 6 3 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -6 -10 -10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 19.4 -67.9 -0.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.8 -1.1 -1.2 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 12 8 1 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 21 15 6 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -11 -7 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 4 4 Lock Lock Lock
Equity $m Lock Lock Lock Lock 16 11 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 17 11 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -22.0 -32.3 -83.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -34.3 -79.1 -194.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -43.4 -105.3 -656.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -47.8 -81.8 -174.7 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -37.2 -83.3 -181.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -29.3 -67.6 -144.0 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -572.3 -375.7 -233.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 1.3 0.7 0.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -67.4 -65.6 -7.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 3.9 3.2 0.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.8 3.1 0.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 79.7 74.8 27.6 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -147.5 -287.8 -227.3 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 3.9 4.0 3.8 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 38.6 30.8 45.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.6 1.2 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 17.0 9.6 19.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.3 0.6 1.2 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.3 0.6 1.2 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -140.7 -155.7 -182.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -46.0 -91.0 -226.4 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -34.3 -79.1 -194.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.3 3.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -43.4 -105.3 -656.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -43.4 -105.3 -656.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 9.5 11.8 8.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 93.9 91.2 96.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 103.3 103.1 104.5 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 27.4 32.8 35.4 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 76.0 70.3 69.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

GTG Shortsell

Frequently Asked Questions

The current share price of Genetic Technologies Limited (GTG:ASX) is AU$0.039.
The 52-week high share price for Genetic Technologies Limited (GTG:ASX) is AU$0.29.
The 52-week low share price for Genetic Technologies Limited (GTG:ASX)? is AU$0.04.
Genetic Technologies Limited (GTG:ASX) does not pay a dividend.
Genetic Technologies Limited (GTG:ASX) does not pay a dividend.
Genetic Technologies Limited (GTG:ASX) has a franking level of 0.0%.
Genetic Technologies Limited (GTG:ASX) is classified in the Industrials.
The current P/E ratio for Genetic Technologies Limited (GTG:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.